Prosecution Insights
Last updated: April 17, 2026
Application No. 18/462,303

Breast Implant Enhancement Device

Final Rejection §102
Filed
Sep 06, 2023
Examiner
MATTHEWS, WILLIAM H
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
unknown
OA Round
4 (Final)
66%
Grant Probability
Favorable
5-6
OA Rounds
3y 4m
To Grant
88%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allow Rate
532 granted / 801 resolved
-3.6% vs TC avg
Strong +21% interview lift
Without
With
+21.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
13 currently pending
Career history
814
Total Applications
across all art units

Statute-Specific Performance

§101
3.5%
-36.5% vs TC avg
§103
31.7%
-8.3% vs TC avg
§102
30.1%
-9.9% vs TC avg
§112
26.0%
-14.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 801 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments filed 9/2/25 have been fully considered but they are not persuasive. Examiner notes Figure 9 describe an open base which provides attachment to the exterior outer posterior surface (see paragraphs 0167+). Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1,8,11,12 is/are rejected under 35 U.S.C. 102a(2) as being anticipated by Contiliano USPUB 20230233737. Contiliano discloses a breast enhancement system (Figures 2,9,12) comprising an enhancement element (inner structure(s) T2/332A/332B//432) selectively coupled to and integrated with a posterior surface of a breast implant via an attachment mechanism, the element having an angular edge (at periphery). The element and breast implant are attached by one of several mechanisms to the inside or outside of the posterior wall. The element having an outer shell of solid material (para [0125]) is considered to be sufficiently rigid as broadly described in Applicant’s specification to meet the function of preventing folding or rippling (Abstract). Regarding claim 8, element may have a domed configuration (Figures). Regarding claim 11, the edge is considered radiused as shown in cross section, or in the top view the edge would appear rounded/radiused. Regarding claim 12, the element comprises an outer shell of a first material filled with a second material (such as gel). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WILLIAM H MATTHEWS whose telephone number is (571)272-4753. The examiner can normally be reached Monday-Friday (9-5). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jerrah Edwards can be reached on 408-918-7557. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WILLIAM H MATTHEWS/Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Sep 06, 2023
Application Filed
Sep 05, 2024
Response Filed
Sep 12, 2024
Non-Final Rejection — §102
Dec 13, 2024
Response Filed
Feb 22, 2025
Final Rejection — §102
Apr 15, 2025
Interview Requested
May 23, 2025
Applicant Interview (Telephonic)
May 23, 2025
Examiner Interview Summary
Jun 27, 2025
Request for Continued Examination
Jul 01, 2025
Response after Non-Final Action
Jul 12, 2025
Non-Final Rejection — §102
Sep 02, 2025
Response Filed
Dec 13, 2025
Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582519
Collapsible And Re-Expandable Prosthetic Heart Valve Cuff Designs And Complementary Technological Applications
2y 5m to grant Granted Mar 24, 2026
Patent 12582525
Implantable Mesh
2y 5m to grant Granted Mar 24, 2026
Patent 12575923
STENTS, SYSTEMS, AND METHODS FOR GASTROINTESTINAL TRACT TREATMENT
2y 5m to grant Granted Mar 17, 2026
Patent 12569343
CATHETER FOR MANIPULATING ANATOMICAL STRUCTURE AND RELATIVE POSITION OF THE CATHETER AND THE ANATOMICAL STRUCTURE
2y 5m to grant Granted Mar 10, 2026
Patent 12564493
Annuloplasty System
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
66%
Grant Probability
88%
With Interview (+21.3%)
3y 4m
Median Time to Grant
High
PTA Risk
Based on 801 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month